3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase 3
2
Phase 2
2
Phase 1/2
2
Phase NA
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
2
Interventions
Specimen Handling
273
Magnetic Resonance Spectroscopy
224
pembrolizumab
214
Carboplatin
173
Biopsy
166
Cisplatin
159
Nivolumab
149
Cyclophosphamide
133
Radiotherapy
117
Paclitaxel
117
Gemcitabine
112
Bevacizumab
92
durvalumab
86
Dexamethasone
80
Rituximab
76
Oxaliplatin
73
atezolizumab
68
Capecitabine
67
venetoclax
66
Fluorouracil
66
Doxorubicin
65
Docetaxel
65
Etoposide
63
Radiosurgery
60
Radiation
57
Prednisone
57
Cytarabine
56
Ipilimumab
55
Pemetrexed
54
Taxes
52
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Trifluridine
×
90 days
×
Clear all
NCT07535632
2026-04-17
BEST
Shanghai Zhongshan Hospital
Phase 2
Not yet recruiting
58 enrolled
NCT06992258
2026-03-17
FRUITION
Criterium, Inc.
Phase 2
Recruiting
120 enrolled